Intimation of Trading window closure to consider and approve Audited Financials for the Quarter and year ended on 31st March 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Skybiotech Healthcare Ltd has informed BSE that its trading window for securities will remain closed from 1st April 2026 until 48 hours after the declaration of audited financial results for the quarter and financial year ended 31st March 2026. This closure is in compliance with SEBI's Insider Trading Regulations, 2015 and the company's own code of conduct. All designated persons and their immediate relatives have been prohibited from trading in the company's shares during this period. The board meeting date to approve the Q4 and FY26 audited financials will be communicated to stock exchanges separately.
This is a routine regulatory compliance filing ahead of the annual results announcement. No direct impact on shareholders, but signals that audited FY26 results will be released in the coming weeks, which is a key event for the stock.